Summary

U.S. Skin Boosters Market Growth & Trends

The U.S. skin boosters market is anticipated to reach USD 650.8 million by 2030 and is anticipated to expand at a CAGR of 8.8% during the forecast period, according to a new report by Grand View Research, Inc. The rising demand for cosmetic procedures from the aging population and the growing medspas are some of the key factors contributing to the market growth. The FDA approvals for skin boosters in the U.S. are an essential element for the market growth.

The increasing number of the aging population in the U.S. demands for an increased number of skin treatments in the country. For instance, according to the U.S. Census Bureau, in 2020, the population aged 65 or older reached a mark of 55.8 million and constitutes 16.8% of the total population of the U.S. This surge in the aging population is anticipated to lead to the demand of cosmetic procedures such as skin boosters, thereby driving the market growth.

U.S. Skin Boosters Market Report Highlights

• Based on type, the mesotherapy segment dominated the market with a revenue share of over 50% in 2023 and is also expected to register the fastest CAGR over the forecast period owing to the rising adoption of the procedure

• Based on gender, the female segment held the largest market share of around 85% in 2023 and is also expected to witness the fastest CAGR over the forecast period pertaining to the growing popularity of the anti-aging non-invasive or minimally invasive cosmetic procedures

• Financial accessibility to non-invasive cosmetic surgeries, increasing consciousness of skincare and beauty and rising geriatric population are contributing to the growing prevalence of the usage of skin boosters treatment.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Gender
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Gender outlook
2.2.3. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. Skin Boosters Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Skin Boosters Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Skin Boosters Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global U.S. Skin Boosters Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Mesotherapy
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Micro-needle
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Skin Boosters Market: Gender Estimates & Trend Analysis
5.1. Gender Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Skin Boosters Market by Treatment Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Female
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Male
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Skin Boosters Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Skin Boosters Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Medical Spa
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Dermatology Clinics
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Bloomage Biotech Co. Ltd.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Medytox Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. AbbVie Inc.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Merz Pharma
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Galderma
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Teoxane
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. IBSA farmaceutici Italia Srl
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. PharmaResearch Co. Ltd.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives